Qiagen NV

QGEN

----

Current ValuationThe current P/E ratio is 27.12, within the reasonable range, cheaper than 36.99% of the time in the past 5 years, and the industry ranks 6/58, the industry Median -1.37.

27.12xP/E

Stock price$50.55Earnings per share$1.86

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x40x80x120x160x200x

P/E ratio
Name/Symbol
TMOUSThermo Fisher Scentific	37.81x	10.09%	$267.38B
DHRUSDanaher	38.19x	24.55%	$165.41B
AUSAgilent Tech	35.27x	12.30%	$50.80B
IQVUSIQVIA	32.96x	2.27%	$45.95B
MTDUSMettler Toledo	37.53x	11.52%	$35.05B
ILMNUSIllumina	37.30x	7.16%	$33.38B
WXXWYUSWuXi Biologics	35.63x	--	$25.67B
MEDPUSMedpace	36.35x	19.31%	$18.82B
ICLRUSICON	35.89x	109.30%	$15.55B
AVTRUSAvantor	31.97x	169.57%	$10.78B
QGENUSQiagen NV	27.12x	7.60%	$10.44B
SHCUSSotera Health	27.07x	145.37%	$4.70B
STVNUSStevanato Group SpA	23.25x	2.87%	$3.75B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.